For decades, Black HIV activists have filled the gaps left by public systems. Today, that carefully built infrastructure hangs in the balance.

Doxy-PEP reshapes STI prevention, while congenital syphilis surges; experts urge scaling HIV and STI care infrastructure to ...

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year.

As GSK’s HIV unit ViiV Healthcare grapples with a new rival in the injectable HIV prevention and treatment field, the company is reinforcing the staying power of its long-acting treatment Cabenuva | ...

A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...

Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.

An initial consignment of 19, 200 doses of Lanacapavir, a six-monthly HIV prevention injection drug, has arrived in Uganda, ...

The Trump administration is moving forward with a sweeping rollback of federal public health funding, cutting $600 million in grants tied to HIV and STD prevention efforts across several states. […] ...

Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...

Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...

The San Francisco Department of Public Health said the federal government terminated four CDC grants totaling more than $8 ...